Dr. Harman Preet Kaur, MD

Dr. Kaur practices at Belt Line Medical Clinic in Mesquite, Texas.

Dr. Kaur's NPI, 1043434152, was assigned on April 12, 2007. Dr. Kaur holds New York license 259391.

Dr. Kaur's primary practice is Belt Line Medical Clinic, at 4321 N Belt Line Rd, Mesquite, TX 75150-3133. The practice phone is (206) 251-7212.

Dr. Kaur's primary practice is Belt Line Medical Clinic in Mesquite, Texas. The medical group on file is Poppy Drive Inpatient Services.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaur practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Kaur's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Kaur's licenses on file in 2 states: New York and Texas.

CMS data shows 158 Medicare services from Dr. Kaur across 5 procedure codes in 2024, for 38 Medicare patients. Medicare paid $12,463 for them. Every service was in an office.

CMS counts 38 Medicare patients who saw Dr. Kaur in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kaur's median patient age at 55, with 66% women.

In 2024, Dr. Kaur wrote 1,682 Medicare Part D claims for 105 patients. 85% of them were for generic drugs. CMS names the drug for 1,300 of them, across 39 drugs with 11 or more claims each, at $148,446 in total drug cost. In 2023, CMS named 1,233 claims across 41 drugs.

Dr. Kaur accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaur as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Kaur from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $18.